NCT01511393View on ClinicalTrials.gov

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Enrolling by invitationOBSERVATIONAL

Enrollment

6,750

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2039

Study Completion Date

December 31, 2039

Conditions

DiabetesDiabetes Mellitus, Type 2Medullary Thyroid CarcinomaWeight Management

Interventions

OTHER

No treatment given

None. Non-interventional study.

Trial Locations (1)

26505-8065

United BioSource, LLC, Morgantown

Sponsors

Lead Sponsor

Novo Nordisk A/S

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

United BioSource, LLC

INDUSTRY

lead

Novo Nordisk A/S

INDUSTRY